Use of Biodegradable, Chitosan-Based Nanoparticles in the Treatment of Alzheimer’s Disease

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that affects more than 24 million people worldwide and represents an immense medical, social and economic burden. While a vast array of active pharmaceutical ingredients (API) is available for the prevention and possibly treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Manek, Eniko, Darvas, Ferenc, Petroianu, Georg A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587961/
https://www.ncbi.nlm.nih.gov/pubmed/33096898
http://dx.doi.org/10.3390/molecules25204866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587961/
https://www.ncbi.nlm.nih.gov/pubmed/33096898
http://dx.doi.org/10.3390/molecules25204866

Ejemplares similares